Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Cash & Equivalents (2019 - 2026)

Nkarta (NKTX) posted quarterly Cash & Equivalents of $27.4 million for Q1 2026, down 47.99% year-over-year from $52.6 million in Q1 2025, and down 30.98% quarter-over-quarter from $39.6 million in Q4 2025.

Nkarta (NKTX) Cash & Equivalents (2019 - 2026) Analysis & Trends

Nkarta's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $27.4 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents fell 47.99% year-over-year to $27.4 million; the TTM figure through Mar 2026 stood at $27.4 million (down 47.99% YoY), while the FY2025 annual figure was $39.6 million, up 42.19% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $27.4 million, down from $39.6 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $250.3 million in Q1 2024, with the low at $27.4 million in Q1 2026.
  • The 5-year median for Cash & Equivalents is $41.6 million (2022), against an average of $64.2 million.
  • The sharpest annual moves came in 2022 and 2025: Cash & Equivalents soared 439.07% in 2022, then slumped 78.98% in 2025.
  • Nkarta's Cash & Equivalents stood at $37.5 million in 2022, then decreased by 17.21% to $31.0 million in 2023, then declined by 10.2% to $27.9 million in 2024, then soared by 42.19% to $39.6 million in 2025, then slumped by 30.98% to $27.4 million in 2026.
  • Business Quant data shows NKTX's Cash & Equivalents at $27.4 million in Q1 2026, $39.6 million in Q4 2025, and $60.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Nkarta 201.14 Mn 201.14 Mn - 243.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 243.20 Mn
Mar 31, 2026 27.36 Mn
Dec 31, 2025 39.63 Mn
Sep 30, 2025 60.11 Mn
Jun 30, 2025 53.41 Mn
Mar 31, 2025 52.60 Mn
Dec 31, 2024 27.87 Mn
Sep 30, 2024 56.96 Mn
Jun 30, 2024 120.40 Mn
Mar 31, 2024 250.29 Mn
Dec 31, 2023 31.04 Mn
Sep 30, 2023 38.26 Mn
Jun 30, 2023 29.12 Mn
Mar 31, 2023 53.67 Mn
Dec 31, 2022 37.49 Mn
Sep 30, 2022 39.65 Mn
Jun 30, 2022 131.65 Mn
Mar 31, 2022 41.61 Mn
Dec 31, 2021 60.82 Mn
Sep 30, 2021 96.22 Mn